Prot #AV-951-12-204: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Multi-Center Study Comparing Tivozanib Hydrochloride In Combination With Paclitaxel Versus Placebo In Combination With Paclitaxel in the Treatment of Subjects With Locally

Project: Research project

Project Details

StatusFinished
Effective start/end date6/20/13 → 6/20/19

Funding

  • AVEO Pharmaceuticals, Inc. (Prot #AV-951-12-204)